alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 32.4



Statement



Pursuant to §906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. §1350, the undersigned officer of Paperweight Development Corp. (the
Company), hereby certifies that to his knowledge:



| | (1) | the Companys Quarterly Report on Form 10-Q for the quarter ended April 3, 2005 fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities
Exchange Act of 1934, and
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | (2) | the information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|                    |  |                               |  |                        
|------------------- |  | ----------------------------- |  | -----------------------
|                    |  | PAPERWEIGHT DEVELOPMENT CORP.
|                    |  |                              
|Dated: May 18, 2005 |  |                               |  | /s/ Dale E. Parker     
|                    |  | Name:                         |  | Dale E. Parker         
|                    |  | Title:                        |  | Chief Financial Officer



This certification accompanies this
Quarterly Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of the Securities Exchange Act of 1934.
<PAGE>
 
                                                                    Exhibit 23.1

    Consent of Ernst & Young LLP, Independent Auditors

We consent to the incorporation by reference in the Registration Statements
(Form S-8 No. 333-11139) pertaining to the Boston Communications Group, Inc.
1996 Stock Option Plan, (Form S-8 No. 333-11191) pertaining to the Boston
Communications Group, Inc. Non-Qualified Stock Options Pursuant to Written
Option Agreements and (Form S-8 No. 333-11195) pertaining to the Boston
Communications Group, Inc. 1996 Employee Stock Purchase Plan of our report dated
February 6, 1998, with respect to the consolidated financial statements
and schedule of Boston Communications Group, Inc. included in the Annual Report
(Form 10-K) for the year ended December 31, 1997.

                                         Ernst & Young LLP


Boston, Massachusetts
March 19, 1998
<PAGE>   1
                                                                  EXHIBIT 21.1


EXHIBIT 21.1   SUBSIDIARIES OF THE REGISTRANT

                       State of
                     Incorporation          Name of Subsidiary
                     --------------         ------------------

                     Michigan               ALS-Midwest, Inc.

                     Delaware               ALS-Crossings Co.

                     Delaware               ALS-Clare Bridge, Inc.

                     Delaware               ALS Leasing, Inc.

                     Delaware               ALS-Stonefield, Inc.

                     Delaware               ALS-WovenHearts, Inc.

                     Delaware               ALS-WovenHearts Minnesota, Inc.

                     Delaware               ALS-Wynwood, Inc.

                     Wisconsin              Heartland Retirement Services, Inc.

                     Wisconsin              Wovencare Systems, Inc.

                     Washington             Crossings International Corporation








                                       57
<TABLE> <S> <C>
                              
<ARTICLE>                          5
<CIK>                              0001013167
<NAME>                             Smith Barney Mid-West Futures Fund L.P. II
                                    
<S>                                  <C>
<PERIOD-TYPE>                      12-MOS
<FISCAL-YEAR-END>                  DEC-31-1996
<PERIOD-START>                     JAN-01-1996
<PERIOD-END>                       DEC-31-1996
<CASH>                              70,073,574
<SECURITIES>                         1,353,865
<RECEIVABLES>                          219,709
<ALLOWANCES>                                0
<INVENTORY>                                 0
<CURRENT-ASSETS>                    71,647,148
<PP&E>                                      0
<DEPRECIATION>                              0
<TOTAL-ASSETS>                      71,647,148
<CURRENT-LIABILITIES>                3,195,679
<BONDS>                                     0
<PREFERRED-MANDATORY>                       0
<PREFERRED>                                 0
<COMMON>                                    0
<OTHER-SE>                          68,451,469
<TOTAL-LIABILITY-AND-EQUITY>        71,647,148
<SALES>                                     0
<TOTAL-REVENUES>                    18,518,297
<CGS>                                       0
<TOTAL-COSTS>                               0
<OTHER-EXPENSES>                     4,771,561
<LOSS-PROVISION>                            0
<INTEREST-EXPENSE>                          0
<INCOME-PRETAX>                     13,746,736
<INCOME-TAX>                                0
<INCOME-CONTINUING>                         0
<DISCONTINUED>                              0
<EXTRAORDINARY>                             0
<CHANGES>                                   0
<NET-INCOME>                        13,746,736
<EPS-PRIMARY>                              319.87
<EPS-DILUTED>                               0
        



</TABLE>
[Federal Register Volume 89, Number 23 (Friday, February 2, 2024)]
[Notices]
[Page 7400]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-02106]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Commission on Childhood Vaccines Meeting; Correction

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: HRSA published a notice in the Federal Register on October 12, 
2023, concerning the 2024 calendar year meetings of the Advisory 
Commission on Childhood Vaccines (ACCV). The meeting times have 
changed. The 2024 ACCV meetings will be held from 1 p.m. eastern time 
(ET)-4 p.m. ET instead of from 10 a.m.-4 p.m.

FOR FURTHER INFORMATION CONTACT: Pita Gomez, Principal Staff Liaison, 
Division of Injury Compensation Programs, HRSA, 5600 Fishers Lane, 8W-
25A, Rockville, Maryland 20857; 800-338-2382; or <a href="/cdn-cgi/l/email-protection#8fceccccd9cfe7fdfceea1e8e0f9"><span class="__cf_email__" data-cfemail="b3f2f0f0e5f3dbc1c0d29dd4dcc5">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION:

Correction

    In the Federal Register of October 12, 2023, FR Doc. 2023-22584, 
page 70680, column 2, correct the Dates caption to read: ``The ACCV 
meetings will be held on:
    <bullet> March 7, 2024, 1 p.m. ET-4 p.m. ET;
    <bullet> March 8, 2023, 1 p.m. ET-4 p.m. ET;
    <bullet> September 5, 2023, 1 p.m. ET-4 p.m. ET;
    <bullet> September 6, 2023, 1 p.m. ET-4 p.m. ET.''

Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2024-02106 Filed 2-1-24; 8:45 am]
BILLING CODE 4165-15-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
II

104TH CONGRESS

2D SESSION S. 2066

To amend the Northern Great Plains Rural Development Act to extend

the duration of the Northern Great Plains Rural Development Commission, and for other purposes.

IN THE SENATE OF THE UNITED STATES

SEPTEMBER 11, 1996

Mr. DASCHLE (for himself, Mr. CONRAD, Mr. DORGAN, Mr. EXON, Mr.

KERREY, Mr. WELLSTONE, Mr. PRESSLER, Mr. GRASSLEY, and Mr.

HARKIN) introduced the following bill; which was read twice and referred

to the Committee on Agriculture, Nutrition, and Forestry

A BILL

To amend the Northern Great Plains Rural Development

Act to extend the duration of the Northern Great Plains

Rural Development Commission, and for other purposes.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. EXTENSION OF NORTHERN GREAT PLAINS

4 RURAL DEVELOPMENT COMMISSION.

5 Section 11 of the Northern Great Plains Rural Devel6 opment Act (Public Law 103–318; 7 U.S.C. 2661 note)

7 is amended by striking ‘‘the earlier’’ and all that follows
2

•S 2066 IS

1 through the period at the end and inserting ‘‘September

2 30, 1997.’’.

Æ
THE THIRTEENTH COURT OF APPEALS

13-23-00362-CV

In the Interest of D.W., A.W., I.W., I.W., Children

On Appeal from the

County Court at Law No. 5 of Nueces County, Texas

Trial Court Cause No. 2021-FAM-60610-5

JUDGMENT

THE THIRTEENTH COURT OF APPEALS, having considered this cause on 

appeal, concludes that the judgment of the trial court be affirmed. The Court orders the 

judgment of the trial court AFFIRMED. No costs are assessed as appellant (S.S.W) filed 

an affidavit of inability to pay costs.

We further order this decision certified below for observance.

January 29, 2024
EXHIBIT 31.2

                            CERTIFICATION PURSUANT TO
                  SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Maurice H. Madrid, certify that:

1. I have reviewed this quarterly  report on Form 10-QSB/A of Sales  Strategies,
Inc.;

2.  Based on my  knowledge,  this  annual  report  does not  contain  any untrue
statement of a material fact or omit to state a material fact  necessary to make
the statements made, in light of the  circumstances  under which such statements
were made,  not  misleading  with  respect to the period  covered by this annual
report;

3.  Based  on my  knowledge,  the  financial  statements,  and  other  financial
information  included  in this annual  report,  fairly  present in all  material
respects the financial  condition,  results of operations  and cash flows of the
registrant as of, and for, the periods presented in this annual report;

4.  The  registrant's  other  certifying  officers  and  I are  responsible  for
establishing and maintaining  disclosure  controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

a) designed  such  disclosure  controls and  procedures  to ensure that material
information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others  within those  entities,  particularly  during the
period in which this annual report is being prepared;

b) evaluated  the  effectiveness  of the  registrant's  disclosure  controls and
procedures  as of a date  within 90 days prior to the filing date of this annual
report (the "Evaluation Date"); and

c) presented in this quarterly report our conclusions about the effectiveness of
the  disclosure  controls  and  procedures  based  on our  evaluation  as of the
Evaluation Date;

5. The registrant's other certifying officers and I have disclosed, based on our
most recent evaluation,  to the registrant's auditors and the audit committee of
registrant's board of directors:

a) all significant  deficiencies in the design or operation of internal controls
which  could  adversely  affect the  registrant's  ability  to record,  process,
summarize and report  financial data and have  identified  for the  registrant's
auditors any material weaknesses in internal controls; and

b) any  fraud,  whether  or not  material,  that  involves  management  or other
employees who have a significant role in the registrant's internal controls; and

6. The  registrant's  other  certifying  officers  and I have  indicated in this
annual report whether or not there were significant changes in internal controls
or in other factors that could significantly affect internal controls subsequent
to the date of our most recent evaluation, including any corrective actions with
regard to significant deficiencies and material weaknesses.

Date: September 22, 2003              /s/ Maurice H. Madrid
                                      ---------------------
                                      Maurice H. Madrid
                                      Acting Financial Officer/
                                      Director
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER>    1,000
       
<S>                             <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1998             DEC-31-1998
<PERIOD-START>                             OCT-01-1998             JAN-01-1998
<PERIOD-END>                               DEC-31-1998             DEC-31-1998
<CASH>                                          18,523                  18,523
<SECURITIES>                                     7,086                   7,086
<RECEIVABLES>                                   18,432                  18,432
<ALLOWANCES>                                   (1,508)                 (1,508)
<INVENTORY>                                      3,525                   3,525
<CURRENT-ASSETS>                                49,953                  49,953
<PP&E>                                          56,497                  56,497
<DEPRECIATION>                                (18,442)                (18,442)
<TOTAL-ASSETS>                                  91,760                  91,760
<CURRENT-LIABILITIES>                           12,556                  12,556
<BONDS>                                              0                       0
<PREFERRED-MANDATORY>                                0                       0
<PREFERRED>                                          0                       0
<COMMON>                                           164                     164  
<OTHER-SE>                                      78,494                  78,494
<TOTAL-LIABILITY-AND-EQUITY>                    91,760                  91,760
<SALES>                                         23,671                  86,482
<TOTAL-REVENUES>                                23,671                  86,482
<CGS>                                           15,527                  60,367
<TOTAL-COSTS>                                   23,550                  89,631
<OTHER-EXPENSES>                                     0                       0
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                               (306)                 (1,349)
<INCOME-PRETAX>                                    427                 (1,800)
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                                427                 (1,800) 
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                       427                 (1,800) 
<EPS-PRIMARY>                                     0.03                  (0.11)  
<EPS-DILUTED>                                     0.03                  (0.11)  
        

</TABLE>
January 12, 2011 

ITo1rioT2roo9 

:^ARTMt^JTOF 

.•':::pOnTATlCM 

The r\A o 5M Honorable Ray LaHood 

Secretary 

U.S. Department of Transportation 

1200 New Jersey Avenue, S.E. 

Washington, D.C. 20590 

Re: Continuation of Alaska Airlines' Essential Air Service at Cordova. Gustavus. 

Petersburo. Wrangell. and Yakutat. Alaska. Docket OST-1998-4899 

Dear Secretary LaHood: 

This letter is to express strong support for the selection of Alaska Airtines to continue to 

provide essential air service to our community. 

Alaska's current pattern of service - using jet aircraft - meets crucial needs that would 

be difficult, if not impossible, to meet with any other type of service or aircraft type: 

Alaska's service connects Southeast Alaska passengers to one or more major 

communities of interest, with single-plane service to Anchorage, Juneau, Ketchikan or 

Seattle. From these hubs, our community can access the airline's extensive route 

system and benefit from its marketing relationships with other carriers. The 737-400 

combination ("combi") passenger and cargo aircraft, which Alaska Airlines proposes to 

continue using on this route, provides freight, mail and cargo capacity that a non-jet 

carrier simply cannot provide. Further, the 737-400 combi aircraft is equipped with 

Required Navigation Performance Technology precision technology, which enables the 

airline to reliably access the airport during inclement weather, thus reducing diversions 

and cancellations and, in turn, enabling people and products to dependably reach the 

community. In sum, Alaska's jet service is critical to the economic well being of our 

community. 

On a personal note, one of our family members had severe medical issues that required 

extensive travel to Seattle. Without this service we would not have been able to provide 

the support during this trying times. 

For these reasons, we respectfully urge DOT to select Alaska Airlines to continue to 

provide essential air service to Southeast Alaska, as the airline has successfully done for 

more than thirty years. 

Sincerely, 

cc: Susan Kurland, Assistant Secretary for Aviation and International Affairs 

Dennis DeVany, Chief, EAS and Domestic Analysis 

The Honorable Sean Parnell, Governor, State of Alaska 
-.•» . 

Marc A. Luiken, Commissioner, Alaska State Department of Transportation and 

Public Facilities
<PAGE>

                                                                    EXHIBIT 21.1

                    UNITED PAYORS & UNITED PROVIDERS, INC.
                             LIST OF SUBSIDIARIES

The Company directly or indirectly owns the following subsidiaries:

  National Health Services, Inc. (a Wisconsin corporation)
  National Health Services of Mississippi, Inc. (a Mississippi corporation)
  Healthcare Review Corporation (a Kentucky corporation)
  Healthcare Review Corporation of Missouri, Inc. (a Missouri corporation)
  Healthcare Review Corporation of New York, Inc. (a New York corporation)
  Medical Network, Inc. (a Delaware corporation)
  NHS Coordinated Care, Inc. (a Nevada corporation)
  NHS Coordinated Care of Texas, Inc. (a Texas corporation)
  IM&I-NEWCO, Inc. (a Delaware corporation)
  America's Health Card Services, Inc. (an Iowa corporation)
Date:
December 15, 2010


Exhibit
31




CERTIFICATION




I, Joel
Gardner, President, CEO, Principal Financial Officer and Principal Accounting
Officer, certify that:




1. I have
reviewed this quarterly report on Form 10-Q of Megola, Inc.;




2. Based
on my knowledge, this quarterly report does not contain any untrue statement of
a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were
made, not misleading with respect to the period covered by this quarterly
report;




3. Based
on my knowledge, the financial statements, and other financial information
included in this quarterly report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as
of, and for, the periods presented in this quarterly report;




4. I am
responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant
and we have:




a)
designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that
material information relating to the registrant is made known to us by others
within the Corporation, particularly during the period in which this quarterly
report is being prepared;




b)
evaluated the effectiveness of the registrant's disclosure controls and
procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered
by this report based on such evaluation; and




c)
disclosed in this report any change in the registrant's internal control over
financial reporting that occurred during the registrant's most recent fiscal
quarter that has materially affected, or is reasonably likely to materially
affect, the registrant's internal control over financial reporting;
and




5. I have
disclosed, based on my most recent evaluation of internal control over financial
reporting, to the registrant's auditors and the audit committee of registrant's
board of directors (or persons performing the equivalent function):




a) all
significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to
adversely affect the registrant's ability to record, process, summarize and
report financial information; and




b) any
fraud, whether or not material, that involves management or other employees who
have a significant role in the registrant's internal control over financial
reporting.




Date:
      December 15, 2010/s/
      JOEL GARDNERJoel
      GardnerPresident,
      CEO, Principal Financial Officer and Principal Accounting
      Officer
<PAGE>
                                                                   EXHIBIT 24.9



                               POWER OF ATTORNEY


The undersigned director and/or officer of Karrington Health, Inc. (the
"Company"), does hereby constitute and appoint Richard R. Slager and Thomas
J. Klimback, or either of them, my true and lawful attorneys and agents, each
with full power of substitution, to do any and all acts and things in my name
and on my behalf in my capacity as a director of the Company and to execute
any and all instruments for me and in my name in the capacity indicated
above, which said attorneys or agents, or either of them, may deem necessary
or advisable to enable the Company to comply with the Securities Exchange Act
of 1934, as amended, and any rules, regulations and requirements of the
Securities and Exchange Commission thereunder, in connection with the filing
requirements of the Company's Annual Report on Form 10-K for the fiscal year
ended December 31, 1997 (the "1997 Form 10-K"), including specifically but
without limitation, power and authority to sign for me in my name, in the
capacity indicated above, the 1997 Form 10-K and any and all amendments to
such 1997 Form 10-K; and I do hereby ratify and confirm all that the said
attorneys and agents, or their substitute or substitutes, or either of them,
shall do or cause to be done by virtue hereof.

                                        /s/ JOHN H. MCCONNELL
                                        John H. McConnell
                                        Director